Paediatric COVID-19 Infection
Dr Mike YW Kwan
Consultant, Paediatric Infectious Diseases Unit,
Department of Paediatrics and Adolescent Medicine,
Hong Kong Hospital Authority Infectious Disease Center, Princess Margaret Hospital
Dr Mike YW Kwan is a Paediatric Immunology and Infectious Diseases specialist. He is the Consultant of Paediatric Infectious Diseases of the Department of Paediatrics and Adolescent Medicine and Hong Kong Hospital Authority Infectious Disease Centre at Princess Margaret Hospital. Dr Kwan is the Past President of The Hong Kong Society for Paediatric Immunology Allergy and Infectious Diseases. He is currently the Chairman of the Paediatric Immunology and Infectious Diseases Subspecialty Board, Hong Kong College of Paediatricians. He is the Standing Committee members representing Hong Kong SAR in the Asian Society for Paediatric Infectious Diseases (ASPID).
Coronavirus disease 2019 (COVID-19) has emerged from Wuhan, China since December 2019. This novel disease has spread to the world in a global scale and the World Health Organization declared the disease as a global pandemic on 11th March 2020. Despite Severe Acute Respiratory Syndrome (SARS) 2003 and COVID-19 were both caused by coronaviruses, the clinical presentations and clinical severity of the two diseases were markedly different. Up to the present moment, findings have indicated that children are less susceptible to SARS-CoV2 virus infection. However, there is a different spectrum of clinical presentation and complication in childhood and adolescent COVID-19 infections. Related “paediatric multisystem inflammatory syndrome temporarily associated with SARS-CoV2” is an important concern to the paediatric population. Since SARS-CoV2 is more prevalent and transmissible, there will be more symptoms to be uncovered as the pandemic progresses. Moreover, asymptomatic children and adolescents are potential sources of infection to their adult family members, which we should pay attention to.
T: +852 2871 8894